• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物促进 GLP-1。

Boosting GLP-1 by Natural Products.

机构信息

Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.

Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran.

出版信息

Adv Exp Med Biol. 2021;1328:513-522. doi: 10.1007/978-3-030-73234-9_36.

DOI:10.1007/978-3-030-73234-9_36
PMID:34981502
Abstract

The prevalence of diabetes mellitus is growing rapidly. Diabetes is the underlying cause of many metabolic and tissue dysfunctions, and, therefore, many therapeutic agents have been developed to regulate the glycemic profile. Glucagon-like peptide-1 (GLP-1) receptor agonists are a newly developed class of antidiabetic drugs that have potent hypoglycemic effects via several molecular pathways. In addition to synthetic GLP-1 receptor agonists, some evidence suggests that natural products may have modulatory effects on GLP-1 expression and secretion. In the current study, we conclude that certain herbal-based constituents, such as berberine, tea, curcumin, cinnamon, wheat, soybean, resveratrol, and gardenia, can exert an influence on GLP-1 release.

摘要

糖尿病的患病率正在迅速增长。糖尿病是许多代谢和组织功能障碍的根本原因,因此已经开发了许多治疗药物来调节血糖谱。胰高血糖素样肽-1(GLP-1)受体激动剂是一类新开发的抗糖尿病药物,通过多种分子途径具有强大的降血糖作用。除了合成的 GLP-1 受体激动剂外,一些证据表明天然产物可能对 GLP-1 的表达和分泌具有调节作用。在本研究中,我们得出结论,某些基于草药的成分,如小檗碱、茶、姜黄素、肉桂、小麦、大豆、白藜芦醇和栀子,可能会影响 GLP-1 的释放。

相似文献

1
Boosting GLP-1 by Natural Products.天然产物促进 GLP-1。
Adv Exp Med Biol. 2021;1328:513-522. doi: 10.1007/978-3-030-73234-9_36.
2
New Injectable Agents for the Treatment of Type 2 Diabetes Part 2-Glucagon-Like Peptide-1 (GLP-1) Agonists.新型 2 型糖尿病治疗药物 第 2 部分:胰高血糖素样肽-1(GLP-1)激动剂。
Am J Med. 2018 Nov;131(11):1304-1306. doi: 10.1016/j.amjmed.2018.05.043. Epub 2018 Jul 2.
3
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.胰高血糖素样肽-1 受体激动剂和二肽基肽酶-4 抑制剂的心血管作用和临床结局。
Circulation. 2017 Aug 29;136(9):849-870. doi: 10.1161/CIRCULATIONAHA.117.028136.
4
Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.胰高血糖素样肽-1 类似物治疗 2 型糖尿病:现有及新兴药物。
Drugs. 2011 Sep 10;71(13):1675-88. doi: 10.2165/11592810-000000000-00000.
5
Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus.用于治疗2型糖尿病的胰高血糖素样肽-1激动剂的药物遗传学
Curr Clin Pharmacol. 2017;12(4):202-209. doi: 10.2174/1574884713666180221121512.
6
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.双重葡萄糖依赖性胰岛素促胰岛素多肽(GIP)和胰高血糖素样肽-1(GLP-1)受体激动剂替西帕肽:一种新的代谢治疗前景。
Cardiovasc Diabetol. 2021 Nov 24;20(1):225. doi: 10.1186/s12933-021-01412-5.
7
Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?胰高血糖素样肽-1 受体激动剂与 2 型糖尿病患者的心血管风险降低:这是一类药物的作用吗?
Curr Cardiol Rep. 2018 Sep 26;20(11):113. doi: 10.1007/s11886-018-1051-2.
8
Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.肥胖型2型糖尿病的治疗策略:聚焦胰高血糖素样肽-1受体激动剂
Clin Ther. 2017 Jun;39(6):1244-1264. doi: 10.1016/j.clinthera.2017.03.013. Epub 2017 May 16.
9
The place of GLP-1-based therapy in diabetes management: differences between DPP-4 inhibitors and GLP-1 receptor agonists.GLP-1 类药物在糖尿病管理中的地位:DPP-4 抑制剂与 GLP-1 受体激动剂的差异。
Curr Diab Rep. 2013 Jun;13(3):307-18. doi: 10.1007/s11892-013-0377-9.
10
Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.胰高血糖素样肽-1受体激动剂在2型糖尿病中的治疗潜力:综述
Expert Rev Clin Pharmacol. 2016;9(2):241-65. doi: 10.1586/17512433.2016.1121808. Epub 2016 Jan 8.

引用本文的文献

1
Postprandial Responses to Animal Products with Distinct Fatty Acid and Amino Acid Composition Are Diet-Dependent.对具有不同脂肪酸和氨基酸组成的动物产品的餐后反应取决于饮食。
Nutrients. 2025 May 4;17(9):1581. doi: 10.3390/nu17091581.
2
A review on the role of functional foods and derivatives for diabetes management.功能性食品及其衍生物在糖尿病管理中的作用综述。
J Food Sci Technol. 2025 May;62(5):799-809. doi: 10.1007/s13197-025-06234-x. Epub 2025 Feb 19.
3
Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential.

本文引用的文献

1
Protective effects of plant-derived natural products on renal complications.植物源天然产物对肾脏并发症的保护作用。
J Cell Physiol. 2019 Aug;234(8):12161-12172. doi: 10.1002/jcp.27950. Epub 2018 Dec 7.
2
Sodium-glucose cotransporter inhibitors and oxidative stress: An update.钠-葡萄糖共转运蛋白抑制剂与氧化应激:最新研究进展。
J Cell Physiol. 2019 Apr;234(4):3231-3237. doi: 10.1002/jcp.26760. Epub 2018 Nov 15.
3
Narrative review of the effects of antidiabetic drugs on albuminuria.糖尿病药物对蛋白尿影响的叙述性综述。
揭示胰高血糖素样肽-1的多方面作用:生理功能与治疗潜力
Toxicol Rep. 2025 Jan 16;14:101895. doi: 10.1016/j.toxrep.2025.101895. eCollection 2025 Jun.
4
Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals.丁香醛通过GLP-1受体信号减轻高糖诱导的H9c2细胞心肌肥大
Pharmaceuticals (Basel). 2025 Jan 16;18(1):110. doi: 10.3390/ph18010110.
5
A Metabolomics Study of the Effects of Eleutheroside B on Glucose and Lipid Metabolism in a Zebrafish Diabetes Model.一种基于斑马鱼糖尿病模型的五味子乙素对糖脂代谢影响的代谢组学研究
Molecules. 2024 Mar 29;29(7):1545. doi: 10.3390/molecules29071545.
6
GLP-1 receptor agonist as a modulator of innate immunity.GLP-1 受体激动剂作为先天免疫调节剂。
Front Immunol. 2022 Dec 8;13:997578. doi: 10.3389/fimmu.2022.997578. eCollection 2022.
7
Berberine: Ins and outs of a nature-made PCSK9 inhibitor.小檗碱:一种天然的前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂的来龙去脉
EXCLI J. 2022 Aug 17;21:1099-1110. doi: 10.17179/excli2022-5234. eCollection 2022.
J Cell Physiol. 2019 May;234(5):5786-5797. doi: 10.1002/jcp.27503. Epub 2018 Oct 26.
4
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.微小 RNA 与 2 型糖尿病:分子机制及抗糖尿病药物治疗的影响。
Metabolism. 2018 Oct;87:48-55. doi: 10.1016/j.metabol.2018.07.001. Epub 2018 Jul 3.
5
Therapeutic potential of curcumin in diabetic complications.姜黄素在糖尿病并发症中的治疗潜力。
Pharmacol Res. 2018 Oct;136:181-193. doi: 10.1016/j.phrs.2018.09.012. Epub 2018 Sep 13.
6
Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study.姜黄素可减轻健康受试者餐后血糖反应:一项交叉、随机对照研究。
Sci Rep. 2018 Sep 12;8(1):13679. doi: 10.1038/s41598-018-32032-x.
7
A review of the molecular mechanisms of hyperglycemia-induced free radical generation leading to oxidative stress.高血糖诱导自由基生成导致氧化应激的分子机制综述。
J Cell Physiol. 2019 Feb;234(2):1300-1312. doi: 10.1002/jcp.27164. Epub 2018 Aug 26.
8
Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids.饮食中的大豆蛋白通过改变肠道微生物群依赖的胆汁酸生物转化来改善高脂肪饮食诱导的肥胖。
PLoS One. 2018 Aug 13;13(8):e0202083. doi: 10.1371/journal.pone.0202083. eCollection 2018.
9
GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.水瓜榴提取物对健康和糖尿病 Wistar 大鼠 GLP-I 分泌的影响。
BMC Complement Altern Med. 2018 May 18;18(1):162. doi: 10.1186/s12906-018-2227-4.
10
Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial.姜黄素加胡椒碱对2型糖尿病患者血糖、肝脏及炎症生物标志物的影响:一项随机双盲安慰剂对照试验
Drug Res (Stuttg). 2018 Jul;68(7):403-409. doi: 10.1055/s-0044-101752. Epub 2018 Feb 19.